// modify the 7 lines below
$alt_texts= array ('Benign prostatic hyperplasia, or BPH for short, is the enlargement of the prostate gland. It is caused by excess growth of cells in the prostate. This condition is not the same as prostate cancer','Alternate Names : Dysmenorrhea. Menstrual cramps are the pain and cramping some women experience during their monthly periods. The term dysmenorrhea usually refers to pain and cramps severe enough to prevent normal activity','An ectopic pregnancy occurs when a fertilized egg implants outside of the uterus. The most common site is within a fallopian tube. More rarely an embryo may implant within an ovary, in the cervix, or on the abdominal wall','Pregnancy is the period from conception to birth. A pregnancy may be complicated by health problems or lifestyle issues known as risk factors. These risk factors can affect the mother or fetus, or both','Topiramate (toe-PYRE-a-mate) is used to help control some types of seizures in the treatment of epilepsy. This medicine cannot cure epilepsy and will only work to help control seizures for as long as you continue to take it.','Irritable bowel syndrome, or IBS, is a condition characterized by abdominal cramping, bloating, gas, and other changes in the bowels','Depression is a medical condition that leads to intense feelings of sadness or despair. These feelings don\'t go away on their own. They are not necessarily related to a particular life event','Tacrolimus ( ta-KROE-li-mus) ointment is used for moderate to severe atopic dermatitis. This is a skin condition where there is itching, redness and inflammation, much like an allergic reaction','Type 2 diabetes mellitus, more often known as type 2 diabetes, is the most common type of diabetes','Personality disorders are chronic mental disorders','Presbyopia is an eye condition in which the lens loses the ability to focus over time');
$links= array('http://www.3-rx.com/benign-prostatic-hyperplasia/default.php','http://www.3-rx.com/menstrual-cramps/default.php','http://www.3-rx.com/ectopic-pregnancy/default.php','http://www.3-rx.com/pregnancy-risk-factors/default.php','http://www.3-rx.com/drugs/detailed/topiramate/default.php','http://www.3-rx.com/irritable-bowel-syndrome/default.php','http://www.3-rx.com/depression.php','http://www.3-rx.com/drugs/detailed/tacrolimus-systemic/before-using.php','http://www.3-rx.com/diabetes.php','http://www.3-rx.com/personality-disorders/default.php','http://www.3-rx.com/presbyopia/default.php'); /* e.g. 'http://www.yoursite.com' */
// YOU DO NOT NEED TO MODIFY BELOW
mt_srand ((double) microtime () * 1000000);
You are here : 3-RX.com > Home > CancerSkin cancer
• Skin cancer
Apr 19 11
Scientists at Yale University have identified a set of plasma biomarkers that could reasonably predict the risk of metastasis among patients with melanoma, according to findings published in Clinical Cancer Research, a journal of the American Association for Cancer Research.
“The rate at which melanoma is increasing is dramatic, and there is a huge number of patients under surveillance,” said Harriet Kluger, M.D., associate professor of medicine at Yale University School of Medicine. “Our current method of surveillance includes periodic imaging, which creates huge societal costs.”
Melanoma is the fifth most common cancer in men and the seventh most common cancer in women. It is estimated that 68,130 people in the United States were diagnosed in 2010, and 8,700 died. With proper screening, melanoma can often be caught early enough to be removed with surgery, and mortality typically comes when the cancer metastasizes. The risk of metastasis varies from less than 10 percent for those with stage 1A melanoma, to as high as 70 percent with stage 3C.
- Full Story - »»»
Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth.
The work was led by Richard Schwab, MD, assistant clinical professor of medicine, and Ajit Varki, MD, professor of medicine and cellular and molecular medicine, with other faculty at the UCSD Moores Cancer Center and the UCSD Glycobiology Research and Training Center. Collaborators include researchers from the groups of Xi Chen at UC Davis, Inder Verma at the Salk Institute and scientists from Sialix, Inc., a biotechnology company based in Vista, CA.
It is published in the April 19 online issue of the journal Cancer Research and in the May 1 print edition.
- Full Story - »»»
Page 1 of 1 pages